AMN HEALTHCARE SERVICES INC
For the period ended Dec 31, 2024. Filed Feb 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 21, 2025
AMN$37.81+0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets as of December 31, 202 and
CONSOLIDATED BALANCE SHEETS
(in thousands, except par value)
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $10,649 | $32,935 |
| Accounts receivable, net of allowances of $32,421 and $32,233 at December 31, 2024 and 2023, respectively | 437,817 | 623,488 |
| Accounts receivable, subcontractor | 70,481 | 117,703 |
| Prepaid expenses | 22,510 | 21,889 |
| Other current assets | 53,458 | 45,670 |
| Total current assets | 594,915 | 841,685 |
| Restricted cash, cash equivalents and investments | 71,840 | 68,845 |
| Fixed assets, net of accumulated depreciation of $360,795 and $285,081 at December 31, 2024 and 2023, respectively | 186,270 | 191,385 |
| Other assets | 258,053 | 236,796 |
| Deferred income taxes, net | 25,829 | — |
| Goodwill | 897,456 | 1,111,549 |
| Intangible assets, net of accumulated amortization of $534,822 and $442,052 at December 31, 2024 and 2023, respectively | 381,364 | 474,134 |
| Total assets | $2,415,727 | $2,924,394 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable and accrued expenses | $184,311 | $343,847 |
| Accrued compensation and benefits | 287,544 | 278,536 |
| Other current liabilities | 73,930 | 33,738 |
| Total current liabilities | 545,785 | 656,121 |
| Revolving credit facility | 210,000 | 460,000 |
| Notes payable, net of unamortized fees and premium | 845,872 | 844,688 |
| Deferred income taxes, net | — | 23,350 |
| Other long-term liabilities | 107,450 | 108,979 |
| Total liabilities | 1,709,107 | 2,093,138 |
| Commitments and contingencies | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.01 par value; 10,000 shares authorized; none issued and outstanding at December 31, 2024 and 2023 | — | — |
| Common stock, $0.01 par value; 200,000 shares authorized; 50,692 issued and 38,079 outstanding at December 31, 2024 and 50,423 issued and 37,810 outstanding at December 31, 2023 | 507 | 504 |
| Additional paid-in capital | 528,471 | 506,543 |
| Treasury stock, at cost; 12,613 shares at December 31, 2024 and 2023 | (1,127,043) | (1,127,043) |
| Retained earnings | 1,304,696 | 1,451,675 |
| Accumulated other comprehensive loss | (11) | (423) |
| Total stockholders’ equity | 706,620 | 831,256 |
| Total liabilities and stockholders’ equity | $2,415,727 | $2,924,394 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.